Jia-Horng Kao*, Pei-Jer Chen*, Ming-Yang Lai*, Ding-Shinn Chen‡,§ 

Slides:



Advertisements
Similar presentations
Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Advertisements

Volume 15, Pages (February 2017)
Value in Health Regional Issues
Volume 60, Issue 2, Pages (February 2014)
Volume 59, Issue 1, Pages (July 2013)
It's time to bring the best and brightest back to gastroenterology!
Volume 50, Issue 4, Pages (April 2009)
Volume 136, Issue 2, Pages (February 2009)
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection  Yi–Cheng Chen, I.–Shyan Sheen,
Volume 39, Issue 6, Pages (December 2003)
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Volume 136, Issue 4, Pages (April 2009)
Volume 122, Issue 3, Pages (March 2002)
Volume 136, Issue 4, Pages (April 2009)
Volume 116, Issue 2, Pages (February 1999)
Leptin, obesity, and liver disease
Volume 123, Issue 6, Pages (December 2002)
Level of Hepatitis B Virus DNA in Inactive Carriers With Persistently Normal Levels of Alanine Aminotransferase  Chia–Ming Chu, Yi–Cheng Chen, Dar–In.
Hepatitis B and C virus-related carcinogenesis
Value in Health Regional Issues
Virological tools to diagnose and monitor hepatitis C virus infection
Volume 127, Issue 6, Pages (December 2004)
Yuying Chen, MD, PhD, Michael J. DeVivo, DrPH, Amie B. Jackson, MD 
Hepatitis B infection in heart transplant recipients
Volume 118, Issue 4, Pages (April 2000)
Diagnosing autoimmune hepatitis in children: Is the International Autoimmune Hepatitis Group scoring system useful?  Regan L. Ebbeson, Richard A. Schreiber 
Volume 133, Issue 5, Pages (November 2007)
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C  Chi–Jen Chu, Munira Hussain,
Volume 154, Issue 4, Pages (March 2018)
Synergistic Effects of Family History of Hepatocellular Carcinoma and Hepatitis B Virus Infection on Risk for Incident Hepatocellular Carcinoma  Rohit.
Yasuhiko Sugawara, Masatoshi Makuuchi 
L. -W. Song, P. -G. Liu, C. -J. Liu, T. -Y. Zhang, X. -D. Cheng, H. -L
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients  Yao-Chun.
Volume 78, Issue 1, Pages (July 2010)
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
Navigating the Maze of Hepatitis B Treatments
An evidence-based medicine approach to studies of diagnostic tests: Assessing the validity of virtual colonoscopy  Brooks D. Cash, Philip Schoenfeld,
Volume 120, Issue 4, Pages (March 2001)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection  Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.
Severe Constipation Clinical Gastroenterology and Hepatology
Lei Yu, Dana A. Sloane, Chuanfa Guo, Charles D. Howell 
William D. Leslie  Clinical Gastroenterology and Hepatology 
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus.
Hepatic Infarction and Hepatic Artery Pseudoaneurysm With Peritoneal Bleeding After Radiofrequency Ablation for Hepatoma  Chiao-Hsiung Chuang, Chiung-Yu.
Hepatitis B and C virus-related carcinogenesis
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected.
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Volume 136, Issue 2, Pages (February 2009)
Volume 50, Issue 4, Pages (April 2009)
Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg 
Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6
Alan Bonder, MD, Nezam H. Afdhal, MD 
Chronic Diarrhea Clinical Gastroenterology and Hepatology
Volume 41, Issue 4, Pages (October 2004)
Yun-Fan Liaw, Wen-Juei Jeng, Ming-Ling Chang  Gastroenterology 
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
Volume 126, Issue 4, Pages (April 2004)
Hepatitis C Genotypes: Current Trends and Future Implications
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection  Yi–Cheng Chen, I.–Shyan Sheen,
Projected National Impact of Colorectal Cancer Screening on Clinical and Economic Outcomes and Health Services Demand  Uri Ladabaum, Kenneth Song  Gastroenterology 
Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study  Jessica A. Davila, Hashem B. El–Serag  Clinical.
Natural Course of Asymptomatic Hepatitis C Virus–Infected Patients and Hepatocellular Carcinoma After Interferon Therapy  Takeshi Okanoue, Masahito Minami,
Scott K. Fung, Anna S.F. Lok  Clinical Gastroenterology and Hepatology 
Volume 130, Issue 3, Pages (March 2006)
Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma  Jin-de Chen, Chun-jen Liu, Po-huang Lee, Pei-jer.
Volume 120, Issue 4, Pages (March 2001)
Volume 156, Issue 4, Pages (March 2019)
Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients  D. He, S. Guo, P. Zhu, S. Tao, M. Li,
Presentation transcript:

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B  Jia-Horng Kao*, Pei-Jer Chen*, Ming-Yang Lai*, Ding-Shinn Chen‡,§  Gastroenterology  Volume 118, Issue 3, Pages 554-559 (March 2000) DOI: 10.1016/S0016-5085(00)70261-7 Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 1 Genotypes of hepatitis B virus in 100 asymptomatic HBsAg-positive carriers stratified by age. The prevalence of genotype C (▨) tended to decrease in older patients (41% in carriers ≤35 years vs. 13% in those >65 years; p = 0.03). The prevalence of genotype B (2) remained unchanged in different age groups (56% in carriers ≤35 years vs. 42% in those >65 years; P = 0.4). ■, Other genotypes. The positive rates of HBeAg in the 4 different age groups were 59%, 16%, 4%, and 0%, respectively. Gastroenterology 2000 118, 554-559DOI: (10.1016/S0016-5085(00)70261-7) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 2 Genotypes of hepatitis B virus in 80 patients with HCC stratified by age. The prevalence of genotype B (2) in HCC patients younger than 35 years was even greater than that in asymptomatic carriers (90% vs. 52%, P < 0.05), and showed a gradual decrease to 40% in those older than 66 years (P = 0.06). Genotype C (▨) was not found in HCC patients younger than 35 years, and its prevalence gradually increased from 21% in HCC patients aged between 36 and 50 years to 50% in those older than 66 years. ■, Other genotypes. Gastroenterology 2000 118, 554-559DOI: (10.1016/S0016-5085(00)70261-7) Copyright © 2000 American Gastroenterological Association Terms and Conditions